US Market Growth Seegene USA operates from Irvine with a global parent, providing a strong bridge to US laboratories. The US market is a strategic growth area for multiplex real-time PCR assays targeting infectious diseases, respiratory pathogens, and STDs. Accelerate sales through distributor partnerships, system integrations, and co-marketing with Werfen to extend reach into mid-size and large clinical labs, hospitals, and reference laboratories.

Analytics Upsell STAgora offers real-time data analytics from aggregated testing data, enabling labs to benchmark performance and optimize workflows. This creates an upsell opportunity to existing customers by offering analytics subscriptions, dashboards, and LIMS integrations. Use ROI-focused pilots to demonstrate value and drive adoption alongside Seegene’s assays.

Strategic Partnerships Past collaboration with Werfen demonstrates a path for co-marketing and channel expansion in the US and beyond. Seek additional distribution partners and technology-sharing arrangements with major diagnostics players to broaden market access. Leverage grants and industry partnerships, such as Nature MDx grants, to fund joint R&D and bolster credibility.

Product Portfolio Synergy Seegene’s high-multiplex real-time PCR panels for infectious diseases, respiratory infections, and STDs pair naturally with STAgora and CURECA to offer end-to-end diagnostic solutions. Bundling assays with analytics can increase value per customer and support data-driven decision making. Target labs investing in syndromic testing and next-generation diagnostic workflows.

Industry Event Focus Active participation in ESCMID Global, ADLM, and EUROGIN signals a focused strategy on infectious disease diagnostics. Use these events to run live demonstrations, pilot programs, and co-marketing campaigns that drive lead generation and partner discussions. Prepare event-specific offers to convert inquiries into customers and channel partners.